By Dr George Sharbeen

Book Chapters

Kokkinos J; Sharbeen G; Phillips PA, 2024, 'Management of Primary Pancreatic Cancer', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 386 - 406, http://dx.doi.org/10.1002/9781119756422.ch20

McCarroll JA; Sharbeen G; Kavallaris M; Phillips PA, 2019, 'The use of star polymer nanoparticles for the delivery of siRNA to mouse orthotopic pancreatic tumor models', in RNA interference and cancer therapy : methods and protocols, pp. 329 - 353, http://dx.doi.org/10.1007/978-1-4939-9220-1_23

Sharbeen G; McAlpine SR; Phillips P, 2015, 'HSP47: The New Heat Shock Protein Therapeutic Target', in Topics in Medicinal Chemistry, Springer Berlin Heidelberg, http://dx.doi.org/10.1007/7355_2015_89

Journal articles

Sharbeen G; Kokkinos J; Schulstad G; Pandzic E; Youkhana J; Ma Z; Ignacio RMC; Raina AS; Chiang S; Boyer C; Haghighi KS; Gunawarman M; Goldstein D; Gebski V; Pajic M; Davis ME; Arkell OSM; Kopecky C; Gonzales-Aloy E; Ishak A; Erkan M; Morton JP; Kavallaris M; Gunning PW; Hardeman EC; Johns A; Gill AJ; Whan RM; Mawson A; Pitiyarachchi O; McCarroll JA; Phillips PA, 2026, 'βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer', Cell Death and Disease, 17, http://dx.doi.org/10.1038/s41419-026-08657-6

Sharbeen G; Gonzales-Aloy E; Youkhana J; Kokkinos J; Ignacio RMC; McCarroll JA; Raina AS; Kopecky C; Liu J; Mawson A; Nunez A; Boyer C; Erkan M; Goldstein D; Haghighi KS; Timpson P; Warren SC; Murphy KJ; Gill AJ; Johns AL; Chou A; Pandzic E; Fok S; Whan R; Gebski V; Morton JP; Apte M; Phillips PA, 2026, 'HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer', Oncogene, 45, pp. 3165 - 3180, http://dx.doi.org/10.1038/s41388-026-03865-y

Liu Y; Khosravi F; Yeo D; Söderström B; El-Helou AJ; Reece PJ; Sharbeen G; Phillips PA; Zhu Y, 2026, 'Unlocking the Potentials of Single Extracellular Vesicle Analysis Technologies for Early Detection of Pancreatic Cancer', ACS Nano Medicine, 1, pp. 846 - 870, http://dx.doi.org/10.1021/acsnanomed.5c00113

Wade SJ; Kumar AA; Nitschke SO; Joyce P; Minaei E; Reuter SE; Penney C; Warren H; Shepherd R; Dinoro JN; Wallace GG; Dosseto A; Ansar S; Islam N; Lochhead A; Sharbeen G; Phillips PA; Aghmesheh M; Hawthorne WJ; Vine-Perrow KL, 2026, 'Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy', Advanced Materials, 38, http://dx.doi.org/10.1002/adma.202522617

Ignacio RMC; Forgham H; Ma Z; Jensen A; Sharbeen G; Ruan J; Ziegler DS; Tsoli M; Phillips PA; Mayoh C; Kavallaris M; McCarroll J, 2025, 'Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cells', Cell Communication and Signaling, 23, http://dx.doi.org/10.1186/s12964-025-02241-9

Chiang S; Garcia Netto K; Kokkinos J; Haghighi KS; Raina AS; Youkhana J; Pitiyarachchi O; Truong Q; Wenholz D; Wilkinson J; Laczka O; Li X; Aldilla VR; Kumar N; Goldstein D; Sharbeen G; Phillips PA, 2025, 'CRO-67 has anti-cancer activity in pancreatic tumor cells and stromal cancer-associated fibroblasts', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-09411-2

Schulstad G; Kokkinos J; Youkhana J; Raina AS; Davis ME; Arkell OSM; Netto KG; Boyer C; Goldstein D; Haghighi KS; Sharbeen G; McCarroll JA; Phillips PA, 2025, 'Abstract A067: βIII-tubulin is a dual cell therapeutic target in pancreatic cancer and regulates sensitivity to TRAIL through a DR5-dependent mechanism', Cancer Research, 85, pp. a067 - a067, http://dx.doi.org/10.1158/1538-7445.pancreatic25-a067

Sharbeen G; Youkhana J; Netto KG; Raina AS; Chiang S; Haghighi KS; Kokkinos J; Pitiyarachchi O; Yang J; Wang T; Swarbrick A; Goldstein D; Phillips PA, 2025, 'Abstract B080: Assessing the response of 3D human pancreatic tumor explants to standard chemotherapy', Cancer Research, 85, pp. b080 - b080, http://dx.doi.org/10.1158/1538-7445.pancreatic25-b080

Lin FP-Y; Goldstein D; Grady JP; Napier C; Thavaneswaran S; Pitiyarachchi O; Kansara M; Chantrill LA; Sjoquist K; Thornton K; Raina A; Magenau A; Simes J; Ballinger ML; Sharbeen G; Timpson P; Pajic M; Phillips P; Thomas DM, 2025, 'Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.', JOURNAL OF CLINICAL ONCOLOGY, 43, pp. 4120 - 4120, http://dx.doi.org/10.1200/JCO.2025.43.16_suppl.4120

Ephraums J; Youkhana J; Raina AS; Schulstad G; Croft K; Mawson A; Kokkinos J; Gonzales-Aloy E; Ignacio RMC; McCarroll JA; Boyer C; Goldstein D; Pajic M; Haghighi KS; Johns A; Gill AJ; Erkan M; Initiative (APGI) APCG; Phillips PA; Sharbeen G, 2025, 'MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability', Neoplasia United States, 61, http://dx.doi.org/10.1016/j.neo.2025.101138

Tang R; Tay SS; Sharbeen G; Herrmann D; Youkhana J; Timpson P; Phillips PA; Biro M, 2025, 'Bystander Expression of Atypical Chemokine Receptor 2 Protects T Cells from Chemoattraction towards Cancer-Associated Fibroblasts', European Journal of Immunology, 55, http://dx.doi.org/10.1002/eji.202451215

van der Woude H; Phan K; Kenwright DN; Goossens L; Hally KE; Currie MJ; Kokkinos J; Sharbeen G; Phillips PA; Henry CE, 2024, 'Development of a long term, ex vivo, patientderived explant model of endometrial cancer', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0301413

Chitty JL; Yam M; Perryman L; Parker AL; Skhinas JN; Setargew YFI; Mok ETY; Tran E; Grant RD; Latham SL; Pereira BA; Ritchie SC; Murphy KJ; Trpceski M; Findlay AD; Melenec P; Filipe EC; Nadalini A; Velayuthar S; Major G; Wyllie K; Papanicolaou M; Ratnaseelan S; Phillips PA; Sharbeen G; Youkhana J; Russo A; Blackwell A; Hastings JF; Lucas MC; Chambers CR; Reed DA; Stoehr J; Vennin C; Pidsley R; Zaratzian A; Da Silva AM; Tayao M; Charlton B; Herrmann D; Nobis M; Clark SJ; Biankin AV; Johns AL; Croucher DR; Nagrial A; Gill AJ; Grimmond SM; Chantrill LA; Chou A; Dwarte T; Metcalf XL; Jeong G; Kenyon L; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Hofmann O; Samra JS; Pavlakis N; Arena J; High HA; Asghari R; Merrett ND; Das A; Cosman PH; Ismail K; Stoita A; Williams D; Spigellman A; McLeo D; Kirk J; Kench JG; Grimison P; Sandroussi C; Goodwin A; Mead RS; Tucker K; Andrews L; Texler M; Forrest C; Ballal M; Fletcher D; Beilin M; Feeney K; Epari K; Mukhedkar S; Zeps N; Nguyen NQ; Ruszkiewicz AR; Worthley C; Chen J, 2023, 'A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer', Nature Cancer, 4, pp. 1326 - 1344, http://dx.doi.org/10.1038/s43018-023-00614-y

Kokkinos J; Sharbeen G; Youkhana J; Boyer C; Goldstein D; Haghighi KS; McCarroll JA; Phillips PA, 2022, 'Abstract B076: βIII-Tubulin is a brake on extrinsic cell-death in pancreatic cancer', Cancer Research, 82, pp. b076 - b076, http://dx.doi.org/10.1158/1538-7445.panca22-b076

Kokkinos J; Sharbeen G; Haghighi KS; Youkhana J; Raina A; Pitiyarachchi O; Truong Q; Wenholz D; Laczka O; Kumar N; Goldstein D; Phillips PA, 2022, 'Abstract C073: CRO-67 is a novel therapeutic for pancreatic cancer: Implications for tumor and stromal reprogramming', Cancer Research, 82, pp. c073 - c073, http://dx.doi.org/10.1158/1538-7445.panca22-c073

Ma Z; Wong SW; Forgham H; Esser L; Lai M; Leiske MN; Kempe K; Sharbeen G; Youkhana J; Mansfeld F; Quinn JF; Phillips PA; Davis TP; Kavallaris M; McCarroll JA, 2022, 'Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth', Biomaterials, 285, http://dx.doi.org/10.1016/j.biomaterials.2022.121539

Cong VT; Tilley RD; Sharbeen G; Phillips PA; Gaus K; Gooding JJ, 2021, 'How to exploit different endocytosis pathways to allow selective delivery of anticancer drugs to cancer cells over healthy cells', Chemical Science, 12, pp. 15407 - 15417, http://dx.doi.org/10.1039/d1sc04656j

Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0

Liu D; Sharbeen G; Phillips P; Johns AL; Gill AJ; Chantrill LA; Timpson P; Chou A; Pajic M; Dwarte T; Herrmann D; Vennin C; Cox TR; Pereira B; Ritchie S; Reed DA; Chambers CR; Metcalf X; Nobis M; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Grimmond SM; Hofmann O; Samra JS; Pavlakis N; Arena J; High HA; Asghari R; Merrett ND; Das A; Cosman PH; Ismail K; Stoita A; Williams D; Spigellman A; Lam VW; McLeod D; Kirk J; Kench JG; Grimison P; Sandroussi C; Goodwin A; Mead RS; Tucker K; Andrews L; Texler M; Forrest C; Ballal M; Fletcher D; Beilin M; Feeney K; Epari K; Mukhedkar S; Zeps N; Nguyen NQ; Ruszkiewicz AR; Worthley C; Chen J; Brooke-Smith ME; Papangelis V; Clouston AD; Barbour AP; O’Rourke TJ; Fawcett JW; Slater K; Hatzifotis M; Hodgkinson P; Nikfarjam M; Eshleman JR; Hruban RH; Wolfgang CL; Scarpa A; Lawlor RT; Corbo V; Bassi C; Biankin AV; Jamieson NB; Chang DK; Dreyer SB; Ford CE, 2021, 'ROR1 and ROR2 expression in pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08952-9

Cong VT; Wang W; Tilley RD; Sharbeen G; Phillips PA; Gaus K; Gooding JJ, 2021, 'Can the Shape of Nanoparticles Enable the Targeting to Cancer Cells over Healthy Cells?', Advanced Functional Materials, 31, http://dx.doi.org/10.1002/adfm.202007880

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496

Nemec S; Lam J; Zhong J; Heu C; Timpson P; Li Q; Youkhana J; Sharbeen G; Phillips PA; Kilian KA, 2021, 'Interfacial Curvature in Confined Coculture Directs Stromal Cell Activity with Spatial Corralling of Pancreatic Cancer Cells', Advanced Biology, 5, pp. e2000525, http://dx.doi.org/10.1002/adbi.202000525

Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA, 2021, 'Does the microenvironment hold the hidden key for functional precision medicine in pancreatic cancer?', Cancers, 13, http://dx.doi.org/10.3390/cancers13102427

Nemec S; Lam J; Zhong J; Heu C; Timpson P; Li Q; Youkhana J; Sharbeen G; Phillips PA; Kilian KA, 2021, 'Cancer‐Associated Fibroblasts: Interfacial Curvature in Confined Coculture Directs Stromal Cell Activity with Spatial Corralling of Pancreatic Cancer Cells (Adv. Biology 6/2021)', Advanced Biology, 5, http://dx.doi.org/10.1002/adbi.202170064

Kokkinos J; Ignacio RM; Haghighi K; Kopecky C; Sharbeen G; Gonzales-Aloy E; Youkhana J; Butler L; Goldstein D; McCarroll J; Phillips P, 2021, 'Patient-derived pancreatic tumours in a dish: implications for real-time precision medicine', Hepato Pancreato Biliary, 23, pp. s235, http://dx.doi.org/10.1016/j.hpb.2020.11.590

Kokkinos J; Ignacio RMC; Sharbeen G; Boyer C; Gonzales-Aloy E; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs', Biomaterials, 240, http://dx.doi.org/10.1016/j.biomaterials.2019.119742

Tjandra KC; McCarthy N; Yang L; Laos AJ; Sharbeen G; Phillips PA; Forgham H; Sagnella SM; Whan RM; Kavallaris M; Thordarson P; McCarroll JA, 2020, 'Identification of Novel Medulloblastoma Cell-Targeting Peptides for Use in Selective Chemotherapy Drug Delivery', Journal of Medicinal Chemistry, 63, pp. 2181 - 2193, http://dx.doi.org/10.1021/acs.jmedchem.9b00851

Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P, 2017, 'MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity', Oncotarget, 8, pp. 9216 - 9229, http://dx.doi.org/10.18632/oncotarget.13985

Thientosapol ES; Sharbeen G; Edwin Lau KK; Bosnjak D; Durack T; Stevanovski I; Weninger W; Jolly CJ, 2017, 'Proximity to AGCT sequences dictates MMR-independent versus MMR-dependent mechanisms for AID-induced mutation via UNG2', Nucleic Acids Research, 45, pp. 3146 - 3157, http://dx.doi.org/10.1093/nar/gkw1300

Akerman A; Vennin C; Sharbeen G; Warren SC; Timpson P; Phillips PA, 2016, 'Novel therapeutics and preclinical imaging for pancreatic cancer - View from the lab', Cancer Forum, 40, pp. 16 - 22

Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia United States, 18, pp. 753 - 764, http://dx.doi.org/10.1016/j.neo.2016.10.011

Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HTT; Liu J; Sharbeen G; Goldstein D; Davis TP; Kavallaris M; Phillips PA, 2016, 'A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo.', Biomacromolecules, 17, pp. 2337 - 2351, http://dx.doi.org/10.1021/acs.biomac.6b00185

Sharbeen G; Youkhana J; McCarroll J; Akerman A; Goldstein D; Phillips P, 2016, 'MutY-Homolog modulates pancreatic cancer cell survival and chemoresistance', Pancreatology, 16, pp. S5 - S5, http://dx.doi.org/10.1016/j.pan.2016.05.024

Sharbeen G; McCarroll J; Goldstein D; Phillips PA, 2015, 'Exploiting Base Excision Repair to Improve Therapeutic Approaches for Pancreatic Cancer', Frontiers in Nutrition, 2, pp. 10, http://dx.doi.org/10.3389/fnut.2015.00010

McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M; Johns AL; Biankin AV; Kavallaris M; Phillips PA; Johns A, 2015, 'βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer', Oncotarget, 6, pp. 2235 - 2249, http://dx.doi.org/10.18632/oncotarget.2946

McCarroll JA; Naim S; Sharbeen G; Russia N; Lee J; Kavallaris M; Goldstein D; Phillips PA, 2014, 'Role of pancreatic stellate cells in chemoresistance in pancreatic cancer', Frontiers in Physiology, 5 APR, pp. 141, http://dx.doi.org/10.3389/fphys.2014.00141

Teo J; Erlich RB; Sagnella S; Dwarte T; Davis TP; Kavallaris M; McCarroll J; Boyer C; Duong HTT; Phillips P; Sharbeen G; Goldstein D, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, 10, pp. 2435 - 2444, http://dx.doi.org/10.1021/mp400049e

Sharbeen G; Yee CWY; Smith AL; Jolly CJ, 2012, 'Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase', Journal of Experimental Medicine, 209, pp. 965 - 974, http://dx.doi.org/10.1084/jem.20112379

Yao TW; Kim WS; Yu DMT; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD, 2011, 'A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling', Molecular Cancer Research, 9, pp. 948 - 959, http://dx.doi.org/10.1158/1541-7786.MCR-10-0272

Sharbeen G; Cook AJL; Lau KKE; Raftery J; Yee CWY; Jolly CJ, 2010, 'Incorporation of dUTP does not mediate mutation of A:T base pairs in Ig genes in vivo', Nucleic Acids Research, 38, pp. 8120 - 8130, http://dx.doi.org/10.1093/nar/gkq682

Peters KM; Sharbeen G; Theis T; Skurray RA; Brown MH, 2009, 'Biochemical characterization of the multidrug regulator QacR distinguishes residues that are crucial to multidrug binding and induction of qacA transcription', Biochemistry, 48, pp. 9794 - 9800, http://dx.doi.org/10.1021/bi901102h

Conference Papers

Kokkinos J; Sharbeen G; Haghighi KS; Youkhana J; Raina A; Pitiyarachchi O; Truong Q; Wenholz D; Laczka O; Kumar N; Goldstein D; Phillips PA, 2022, 'CRO-67 is a novel therapeutic for pancreatic cancer: Implications for tumor and stromal reprogramming.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, pp. 161 - 161, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 13 September 2022 - 16 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899825600205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kokkinos J; Sharbeen G; Youkhana J; Boyer C; Goldstein D; Haghighi KS; McCarroll JA; Phillips PA, 2022, 'ßIII-Tubulin is a brake on extrinsic cell-death in pancreatic cancer.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, pp. 108 - 109, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 13 September 2022 - 16 September 2022

Kokkinos J; Sharbeen G; Mccarroll J; Akerman A; Youkhana J; Goldstein D; Phillips P, 2018, 'beta III-Tubulin is a brake for external cell-death signaling and chemosensitivity in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Youkhana J; Mccarroll J; Sharbeen G; Erkan M; Liu J; Goldstein D; Phillips PA, 2014, 'Heat shock protein 47 is a potential therapeutic target for the depletion of cancer-promoting stromal cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page